SAVAYSA



Trademark Coverage

No Class Specified

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use

Timeline
  • Feb 10
    2014
    Abandonment Notice Mailed No Use Statement Filed
  • Feb 10
    2014
    Abandonment No Use Statement Filed
  • Jul 09
    2013
    NOA E Mailed SOU Required From Applicant
  • May 14
    2013
    Official Gazette Publication Confirmation E Mailed
  • May 14
    2013
    Published For Opposition
  • Apr 24
    2013
    Notification Of Notice Of Publication E Mailed
  • Apr 11
    2013
    Law Office Publication Review Completed
  • Apr 10
    2013
    Assigned To LIE
  • Apr 08
    2013
    Approved For PUB Principal Register
  • Apr 03
    2013
    Examiner's Amendment Entered
  • Apr 03
    2013
    Notification Of Examiners Amendment E Mailed
  • Apr 03
    2013
    Examiners Amendment E Mailed
  • Apr 03
    2013
    Examiners Amendment Written
  • Apr 03
    2013
    Assigned To Examiner
  • Feb 07
    2013
    Notice Of Design Search Code E Mailed
  • Feb 06
    2013
    New Application Office Supplied Data Entered In TRAM
  • Feb 04
    2013
    New Application Entered In TRAM